Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balicatib in painful knee osteoarthritis
NCT00371670Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of balicatib in knee osteoarthritis (OA), sponsored by Novartis. Started Dec 2004; status: completed.
02
Drugs
balicatib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00371670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371670.